{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:38:12Z","timestamp":1746319092750,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intergovernmental International Cooperation on Scientific and Technological Innovation project of Chinese Ministry of Science and Technology","award":["2017YFE0131600"],"award-info":[{"award-number":["2017YFE0131600"]}]},{"name":"Guangdong Provincial Outstanding Young Medical Talents Supporting Research Foundation","award":["KJ012019459"],"award-info":[{"award-number":["KJ012019459"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070128"],"award-info":[{"award-number":["82070128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Science and Technology Projects","award":["2017B020230004","2020A0505100042"],"award-info":[{"award-number":["2017B020230004","2020A0505100042"]}]},{"name":"Guangdong Medical Science and Technology Research Fund Project","award":["A2019525"],"award-info":[{"award-number":["A2019525"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common characteristic of this disease and is thought to be related to clinical outcome. Alterations in T cell clonal expansion and T cell dysfunction has been detected in MDS patients. Little is known about whether there are immune biomarkers to evaluate the T cell alterations with clinical outcome. Previous studies have demonstrated that B-cell leukemia\/lymphoma 11B (BCL11B) plays an important role in regulating T cell development and proliferation. In this study, the prognostic value of BCL11B for MDS patients was explored by analyzing RNA-seq data from 270 patients in two datasets in the Gene Expression Omnibus (GEO) database and real-time quantitative PCR data (qRT-PCR) of 31 bone marrow (BM) samples of MDS and 6 BM samples of patients with MDS progress to secondary acute myeloid leukemia (sAML) from our clinical center. The results demonstrated that BCL11B is significantly down-regulated in MDS patients as compared with healthy individuals (HIs). Importantly, lower BCL11B expression was found in MDS patients who were of high\/very high risk, older than 60 y, or male and patients with sAML. Furthermore, low BCL11B expression appeared to be associated with poor overall survival (OS) for MDS patients, though the data were not yet significant enough at this point. In addition, BCL11B low-expressing MDS patients had shorter restricted mean survival time (RMST) than those with high BCL11B expression. Interestingly, BCL11B positively correlated with naive and activated memory CD4\u2009+\u2009T cells, CD8\u2009+\u2009T cells, and the T cell receptor complex genes CD3E and CD3G, but it negatively correlated with regulatory T cells (Treg). Additionally, co-occurrence of low BCL11B expression and CD3E and CD3G was associated with poor OS and shorter RMST. In conclusion, lower BCL11B expression in BM samples of MDS patients was associated with adverse clinical outcome.<\/jats:p>","DOI":"10.1186\/s40364-021-00302-y","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:08:02Z","timestamp":1623352082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-0964","authenticated-orcid":false,"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-9174","authenticated-orcid":false,"given":"Cunte","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-7125","authenticated-orcid":false,"given":"Mengjun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-3367","authenticated-orcid":false,"given":"Suxia","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-4927","authenticated-orcid":false,"given":"Yujie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingji","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-0146","authenticated-orcid":false,"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zesheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-9433","authenticated-orcid":false,"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-4036","authenticated-orcid":false,"given":"Yangqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"12","key":"302_CR1","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454\u201365.","journal-title":"Blood"},{"key":"302_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40164-019-0158-5","volume":"9","author":"J Yu","year":"2020","unstructured":"Yu J, Li Y, Li T, Li Y, Xing H, Sun H, Sun L, Wan D, Liu Y, Xie X, et al. Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia. Exp Hematol Oncol. 2020;9:2.","journal-title":"Exp Hematol Oncol"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-020-0182-y","volume":"8","author":"S Gao","year":"2020","unstructured":"Gao S, Wang S, Song Y. Novel immunomodulatory drugs and neo-substrates. Biomark Res. 2020;8:2.","journal-title":"Biomark Res"},{"issue":"12","key":"302_CR4","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00262-019-02420-x","volume":"68","author":"P Montes","year":"2019","unstructured":"Montes P, Bernal M, Campo LN, Gonz\u00e1lez-Ram\u00edrez AR, Jim\u00e9nez P, Garrido P, Jurado M, Garrido F, Ruiz-Cabello F, Hern\u00e1ndez F. Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression. Cancer Immunol Immunother. 2019;68(12):2015\u201327.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"302_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/ijms17060944","volume":"17","author":"A Glenth\u00f8j","year":"2016","unstructured":"Glenth\u00f8j A, \u00d8rskov AD, Hansen JW, Hadrup SR, O\u2019Connell C, Gr\u00f8nb\u00e6k K. Immune Mechanisms in Myelodysplastic Syndrome. Int J Mol Sci. 2016;17(6):944.","journal-title":"Int J Mol Sci"},{"key":"302_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.critrevonc.2017.12.013","volume":"122","author":"C Wang","year":"2018","unstructured":"Wang C, Yang Y, Gao S, Chen J, Yu J, Zhang H, Li M, Zhan X, Li W. Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies. Crit Rev Oncol Hematol. 2018;122:123\u201332.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"302_CR7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1089\/dna.2012.1769","volume":"31","author":"S Geng","year":"2012","unstructured":"Geng S, Weng J, Du X, Lai P, Huang X, Chen S, Yang L, Li Y. Comparison of the distribution and clonal expansion features of the T-cell \u03b3\u03b4 repertoire in myelodysplastic syndrome-RAEB and RAEB with progression to AML. DNA Cell Biol. 2012;31(10):1563\u201370.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"302_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2162-3619-1-22","volume":"1","author":"X Huang","year":"2012","unstructured":"Huang X, Du X, Li Y. The role of BCL11B in hematological malignancy. Exp Hematol Oncol. 2012;1(1):22.","journal-title":"Exp Hematol Oncol"},{"key":"302_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-014-0051-y","volume":"7","author":"I Bartram","year":"2014","unstructured":"Bartram I, G\u00f6kbuget N, Schlee C, Heesch S, Fransecky L, Schwartz S, Stuhlmann R, Sch\u00e4fer-Eckhart K, Starck M, Reichle A, et al. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients. J Hematol Oncol. 2014;7:51.","journal-title":"J Hematol Oncol"},{"key":"302_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40364-020-00187-3","volume":"8","author":"R Huang","year":"2020","unstructured":"Huang R, Zhou L, Chi Y, Wu H, Shi L. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer. Biomark Res. 2020;8:8.","journal-title":"Biomark Res"},{"key":"302_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2018.09.001","volume":"34","author":"AM Zeidan","year":"2019","unstructured":"Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Rev. 2019;34:1\u201315.","journal-title":"Blood Rev"},{"key":"302_CR12","doi-asserted-by":"crossref","unstructured":"Chen C, Xu L, Gao R, Wang S, Zhang Y, Wang C, Zeng C. Y L. Transcriptome-based co-expression of BRD4 and PD-1\/PD-L1 predicts poor overall survival in patients with acute myeloid leukemia. Front Pharmacol. 2021;11:582955.","DOI":"10.3389\/fphar.2020.582955"},{"issue":"1","key":"302_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-020-00853-x","volume":"13","author":"C Chen","year":"2020","unstructured":"Chen C, Liang C, Wang S, Chio CL, Zhang Y, Zeng C, Chen S, Wang C, Li Y. Expression patterns of immune checkpoints in acute myeloid leukemia. J Hematol Oncol. 2020;13(1):28.","journal-title":"J Hematol Oncol"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-021-00302-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:12:22Z","timestamp":1623352342000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-021-00302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s40364-021-00302-y","relation":{},"ISSN":["2050-7771"],"issn-type":[{"type":"electronic","value":"2050-7771"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Guangdong Provincial People\u2019s Hospital. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"46"}}